{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:05:01Z","timestamp":1789988701111,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"DOI":"10.1038\/s41582-026-01266-z","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:53:41Z","timestamp":1789988021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of microbiota in neuro-oncology"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9460-618X","authenticated-orcid":false,"given":"Golnaz","family":"Morad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-8576","authenticated-orcid":false,"given":"Nadim J.","family":"Ajami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherise D.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-7576","authenticated-orcid":false,"given":"Jennifer A.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","volume":"22","author":"QT Ostrom","year":"2020","unstructured":"Ostrom, Q. T. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro Oncol. 22, iv1\u2013iv96 https:\/\/doi.org\/10.1093\/neuonc\/noaa200 (2020).","journal-title":"Neuro Oncol."},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff, L. R. & Mellinghoff, I. K. Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329, 574\u2013587 https:\/\/doi.org\/10.1001\/jama.2023.0023 (2023).","journal-title":"JAMA"},{"key":"1266_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom, Q. T. et al. The epidemiology of glioma in adults: a \u201cstate of the science\u201d review. Neuro Oncol. 16, 896\u2013913 https:\/\/doi.org\/10.1093\/neuonc\/nou087 (2014).","journal-title":"Neuro Oncol."},{"key":"1266_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba, N., Wen, P. Y. & Aizer, A. A. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 23, 1447\u20131456 https:\/\/doi.org\/10.1093\/neuonc\/noab101 (2021).","journal-title":"Neuro Oncol."},{"key":"1266_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","volume":"614","author":"E Karimi","year":"2023","unstructured":"Karimi, E. et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours. Nature 614, 555\u2013563 https:\/\/doi.org\/10.1038\/s41586-022-05680-3 (2023).","journal-title":"Nature"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald, A. C. et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell 187, 2485\u20132501e2426 https:\/\/doi.org\/10.1016\/j.cell.2024.03.029 (2024).","journal-title":"Cell"},{"key":"1266_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm, F. et al. Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181, 1643\u20131660e1617 https:\/\/doi.org\/10.1016\/j.cell.2020.05.007 (2020).","journal-title":"Cell"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"1266_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703 https:\/\/doi.org\/10.1038\/s41591-022-01779-2 (2022).","journal-title":"Nat. Med."},{"key":"1266_CR10","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877\u20132013 https:\/\/doi.org\/10.1152\/physrev.00018.2018 (2019).","journal-title":"Physiol. Rev."},{"key":"1266_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molmed.2024.08.008","volume":"31","author":"L Keane","year":"2025","unstructured":"Keane, L., Cryan, J. F. & Gleeson, J. P. Exploiting the gut microbiome for brain tumour treatment. Trends Mol. Med. 31, 213\u2013223 https:\/\/doi.org\/10.1016\/j.molmed.2024.08.008 (2025).","journal-title":"Trends Mol. Med."},{"key":"1266_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77919-w","volume":"10","author":"A Patrizz","year":"2020","unstructured":"Patrizz, A. et al. Glioma and temozolomide induced alterations in gut microbiome. Sci. Rep. 10, 21002 https:\/\/doi.org\/10.1038\/s41598-020-77919-w (2020).","journal-title":"Sci. Rep."},{"key":"1266_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04042-5","volume":"21","author":"X Hou","year":"2023","unstructured":"Hou, X. et al. Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma. J. Transl. Med. 21, 198 https:\/\/doi.org\/10.1186\/s12967-023-04042-5 (2023).","journal-title":"J. Transl. Med."},{"key":"1266_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.836953","volume":"12","author":"Y Fan","year":"2022","unstructured":"Fan, Y., Su, Q., Chen, J., Wang, Y. & He, S. Gut microbiome alterations affect glioma development and Foxp3 expression in tumor microenvironment in mice. Front. Oncol. 12, 836953 https:\/\/doi.org\/10.3389\/fonc.2022.836953 (2022).","journal-title":"Front. Oncol."},{"key":"1266_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.111874","volume":"28","author":"M Massara","year":"2025","unstructured":"Massara, M. et al. The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis. iScience 28, 111874 https:\/\/doi.org\/10.1016\/j.isci.2025.111874 (2025).","journal-title":"iScience"},{"key":"1266_CR16","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41591-025-03957-4","volume":"31,","author":"G Morad","year":"2025","unstructured":"Morad, G. et al. Microbial signals in primary and metastatic brain tumors. Nat. Med. 31, 3675\u20133688 https:\/\/doi.org\/10.1038\/s41591-025-03957-4 (2025).","journal-title":"Nat. Med."},{"key":"1266_CR17","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1080\/21655979.2022.2049959","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study. Bioengineered 13, 7847\u20137859 https:\/\/doi.org\/10.1080\/21655979.2022.2049959 (2022).","journal-title":"Bioengineered"},{"key":"1266_CR18","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ccell.2025.09.002","volume":"43","author":"ML Chen","year":"2025","unstructured":"Chen, M. L. et al. Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production. Cancer Cell 43, 2119\u20132135e2110 https:\/\/doi.org\/10.1016\/j.ccell.2025.09.002 (2025).","journal-title":"Cancer Cell"},{"key":"1266_CR19","doi-asserted-by":"publisher","DOI":"10.2217\/cns-2020-0007","volume":"9","author":"A Dono","year":"2020","unstructured":"Dono, A. et al. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol. 9, CNS57 https:\/\/doi.org\/10.2217\/cns-2020-0007 (2020).","journal-title":"CNS Oncol."},{"key":"1266_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201948354","volume":"50","author":"G D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro, G. et al. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice. Eur. J. Immunol. 50, 705\u2013711 https:\/\/doi.org\/10.1002\/eji.201948354 (2020).","journal-title":"Eur. J. Immunol."},{"key":"1266_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112881","volume":"141","author":"M Zhou","year":"2024","unstructured":"Zhou, M. et al. Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment. Int. Immunopharmacol. 141, 112881 https:\/\/doi.org\/10.1016\/j.intimp.2024.112881 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1266_CR22","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/neuonc\/noaf024","volume":"27","author":"J Chatterjee","year":"2025","unstructured":"Chatterjee, J. et al. Intestinal Bacteroides drives glioma progression by regulating CD8+ T cell tumor infiltration. Neuro Oncol. 27, 1579\u20131593 https:\/\/doi.org\/10.1093\/neuonc\/noaf024 (2025).","journal-title":"Neuro Oncol."},{"key":"1266_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab194","volume":"4","author":"A de Andrade Costa","year":"2022","unstructured":"de Andrade Costa, A. et al. Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation. Neurooncol. Adv. 4, vdab194 https:\/\/doi.org\/10.1093\/noajnl\/vdab194 (2022).","journal-title":"Neurooncol. Adv."},{"key":"1266_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf085","volume":"7","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Deciphering the contributions of fecal microbiota from patients with high-grade glioma to tumor development in a humanized microbiome mouse model of glioma. Neurooncol Adv. 7, vdaf085 https:\/\/doi.org\/10.1093\/noajnl\/vdaf085 (2025).","journal-title":"Neurooncol Adv."},{"key":"1266_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.986837","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Bifidobacterium lactis combined with Lactobacillus plantarum inhibit glioma growth in mice through modulating PI3K\/AKT pathway and gut microbiota. Front. Microbiol. 13, 986837 https:\/\/doi.org\/10.3389\/fmicb.2022.986837 (2022).","journal-title":"Front. Microbiol."},{"key":"1266_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab023","volume":"3","author":"KJ Dees","year":"2021","unstructured":"Dees, K. J. et al. Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma. Neurooncol Adv. 3, vdab023 https:\/\/doi.org\/10.1093\/noajnl\/vdab023 (2021).","journal-title":"Neurooncol Adv."},{"key":"1266_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2508432","volume":"17","author":"GBH Green","year":"2025","unstructured":"Green, G. B. H. et al. Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma. Gut Microbes 17, 2508432 https:\/\/doi.org\/10.1080\/19490976.2025.2508432 (2025).","journal-title":"Gut Microbes"},{"key":"1266_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56930-7","volume":"16","author":"SP Weathers","year":"2025","unstructured":"Weathers, S. P. et al. Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I\/II trial. Nat. Commun. 16, 3950 https:\/\/doi.org\/10.1038\/s41467-025-56930-7 (2025).","journal-title":"Nat. Commun."},{"key":"1266_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200787","volume":"32","author":"NM Melendez-Vazquez","year":"2024","unstructured":"Melendez-Vazquez, N. M. et al. Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas. Mol. Ther. Oncol. 32, 200787 https:\/\/doi.org\/10.1016\/j.omton.2024.200787 (2024).","journal-title":"Mol. Ther. Oncol."},{"key":"1266_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.746568","volume":"12","author":"Y Wen","year":"2021","unstructured":"Wen, Y. et al. Association between oral microbiota and human brain glioma grade: a case\u2013control study. Front. Microbiol. 12, 746568 https:\/\/doi.org\/10.3389\/fmicb.2021.746568 (2021).","journal-title":"Front. Microbiol."},{"key":"1266_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/JPER.24-0267","volume":"96","author":"N Yakar","year":"2025","unstructured":"Yakar, N. et al. Subgingival microbial profiles in pre- and postmenopausal women: associations with serum estradiol levels. J. Periodontol. 96, 97\u2013108 https:\/\/doi.org\/10.1002\/JPER.24-0267 (2025).","journal-title":"J. Periodontol."},{"key":"1266_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37284","volume":"10","author":"H Qin","year":"2024","unstructured":"Qin, H., Liu, J., Li, Y. Y., Xu, Y. L. & Yan, Y. F. Gender-specific microbial signatures in saliva: unveiling the association between the oral microbiome and the pathogenesis of glioma. Heliyon 10, e37284 https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37284 (2024).","journal-title":"Heliyon"},{"key":"1266_CR33","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/1055-9965.1583.13.10","volume":"13","author":"K Huang","year":"2004","unstructured":"Huang, K. et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol. Biomarkers Prev. 13, 1583\u20131588 (2004).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1266_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri3785","volume":"15","author":"G Hajishengallis","year":"2015","unstructured":"Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30\u201344 https:\/\/doi.org\/10.1038\/nri3785 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1266_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011141","author":"EA Catalan","year":"2024","unstructured":"Catalan, E. A. et al. Oral pathobiont-derived outer membrane vesicles in the oral\u2013gut axis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms252011141 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1266_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42693","volume":"8","author":"TS Schmidt","year":"2019","unstructured":"Schmidt, T. S. et al. Extensive transmission of microbes along the gastrointestinal tract. eLife 8, e42693 https:\/\/doi.org\/10.7554\/eLife.42693 (2019).","journal-title":"eLife"},{"key":"1266_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41368-018-0043-9","volume":"11","author":"B Li","year":"2019","unstructured":"Li, B. et al. Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice. Int. J. Oral. Sci. 11, 10 https:\/\/doi.org\/10.1038\/s41368-018-0043-9 (2019).","journal-title":"Int. J. Oral. Sci."},{"key":"1266_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.trecan.2023.12.002","volume":"10","author":"L Li","year":"2024","unstructured":"Li, L., Chandra, V. & McAllister, F. Tumor-resident microbes: the new kids on the microenvironment block. Trends Cancer 10, 347\u2013355 https:\/\/doi.org\/10.1016\/j.trecan.2023.12.002 (2024).","journal-title":"Trends Cancer"},{"key":"1266_CR39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 https:\/\/doi.org\/10.1126\/science.aay9189 (2020).","journal-title":"Science"},{"key":"1266_CR40","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia, T. W. et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell 187, 2324\u20132335e2319 https:\/\/doi.org\/10.1016\/j.cell.2024.03.021 (2024).","journal-title":"Cell"},{"key":"1266_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00457-24","volume":"10","author":"T Li","year":"2025","unstructured":"Li, T. et al. Multi-omics analysis reveals the interplay between intratumoral bacteria and glioma. mSystems 10, e0045724 https:\/\/doi.org\/10.1128\/msystems.00457-24 (2025).","journal-title":"mSystems"},{"key":"1266_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1582068","volume":"15","author":"W Li","year":"2025","unstructured":"Li, W. et al. Deciphering the impact of intra-tumoral bacterial infiltration on multi-omics profiles in low-grade gliomas. Front. Oncol. 15, 1582068 https:\/\/doi.org\/10.3389\/fonc.2025.1582068 (2025).","journal-title":"Front. Oncol."},{"key":"1266_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","volume":"617","author":"R Naghavian","year":"2023","unstructured":"Naghavian, R. et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature 617, 807\u2013817 https:\/\/doi.org\/10.1038\/s41586-023-06081-w (2023).","journal-title":"Nature"},{"key":"1266_CR44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/s43018-025-01073-3","volume":"6","author":"E Gigi","year":"2025","unstructured":"Gigi, E. et al. Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures. Nat. Cancer 6, 1761\u20131776 https:\/\/doi.org\/10.1038\/s43018-025-01073-3 (2025).","journal-title":"Nat. Cancer"},{"key":"1266_CR45","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.cell.2025.12.044","volume":"6","author":"B Yao","year":"2026","unstructured":"Yao, B. et al. Divergent tumor immunity determined by bacteria-cancer cell engagement. Cell 6, 1748\u20131767.e26 (2026).\u00a0","journal-title":"Cell"},{"key":"1266_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01607-23","volume":"14","author":"A Gihawi","year":"2023","unstructured":"Gihawi, A. et al. Major data analysis errors invalidate cancer microbiome findings. mBio 14, e0160723 https:\/\/doi.org\/10.1128\/mbio.01607-23 (2023).","journal-title":"mBio"},{"key":"1266_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature 587, 448\u2013454 https:\/\/doi.org\/10.1038\/s41586-020-2881-9 (2020).","journal-title":"Nature"},{"key":"1266_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.24171\/j.phrp.2024.0319","volume":"16","author":"JW Kim","year":"2025","unstructured":"Kim, J. W., Choi, E. C. & Lee, K. J. Standardizing the approach to clinical-based human microbiome research: from clinical information collection to microbiome profiling and human resource utilization. Osong Public Health Res. Perspect. 16, 300\u2013307 https:\/\/doi.org\/10.24171\/j.phrp.2024.0319 (2025).","journal-title":"Osong Public Health Res. Perspect."},{"key":"1266_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1902\/jop.2013.130225","volume":"85","author":"RS de Molon","year":"2014","unstructured":"de Molon, R. S. et al. Evaluation of the host response in various models of induced periodontal disease in mice. J. Periodontol. 85, 465\u2013477 https:\/\/doi.org\/10.1902\/jop.2013.130225 (2014).","journal-title":"J. Periodontol."},{"key":"1266_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41385-022-00564-1","volume":"15","author":"TCA Hitch","year":"2022","unstructured":"Hitch, T. C. A. et al. Microbiome-based interventions to modulate gut ecology and the immune system. Mucosal Immunol. 15, 1095\u20131113 https:\/\/doi.org\/10.1038\/s41385-022-00564-1 (2022).","journal-title":"Mucosal Immunol."},{"key":"1266_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41587-023-01906-5","volume":"42","author":"A Wahl","year":"2024","unstructured":"Wahl, A. et al. A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection. Nat. Biotechnol. 42, 905\u2013915 https:\/\/doi.org\/10.1038\/s41587-023-01906-5 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1266_CR52","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1016\/j.csbj.2021.10.028","volume":"19","author":"H Xiao","year":"2021","unstructured":"Xiao, H. et al. Oral microbiota transplantation fights against head and neck radiotherapy-induced oral mucositis in mice. Comput. Struct. Biotechnol. J. 19, 5898\u20135910 https:\/\/doi.org\/10.1016\/j.csbj.2021.10.028 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"1266_CR53","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/neuonc\/noae131","volume":"26","author":"J Figg","year":"2024","unstructured":"Figg, J., Chen, D., Falceto Font, L., Flores, C. & Jin, D. In vivo mouse models for adult brain tumors: exploring tumorigenesis and advancing immunotherapy development. Neuro Oncol. 26, 1964\u20131980 https:\/\/doi.org\/10.1093\/neuonc\/noae131 (2024).","journal-title":"Neuro Oncol."},{"key":"1266_CR54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-0291","author":"M Valiente","year":"2020","unstructured":"Valiente, M. et al. Brain metastasis cell lines panel: a public resource of organotropic cell lines. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0291 (2020).","journal-title":"Cancer Res."},{"key":"1266_CR55","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cne.24971","volume":"529","author":"K Hakvoort","year":"2021","unstructured":"Hakvoort, K. et al. Shedding light on human cerebral lipofuscin: An explorative study on identification and quantification. J. Comp. Neurol. 529, 605\u2013615 https:\/\/doi.org\/10.1002\/cne.24971 (2021).","journal-title":"J. Comp. Neurol."},{"key":"1266_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202200357","volume":"16","author":"D He","year":"2023","unstructured":"He, D., Li, T., Yang, X., Xu, Y. & Sun, H. Sudan Black B treatment for reducing autofluorescence in human glioma tissue and improving fluorescent signals of bacterial LPS staining. J. Biophotonics 16, e202200357 https:\/\/doi.org\/10.1002\/jbio.202200357 (2023).","journal-title":"J. Biophotonics"},{"key":"1266_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102492","volume":"4","author":"CM Phelps","year":"2023","unstructured":"Phelps, C. M., Shapira, J. H., Laughlin, C. R. & Meisel, M. Detection of viable commensal bacteria in murine melanoma tumors by culturomics. STAR Protoc. 4, 102492 https:\/\/doi.org\/10.1016\/j.xpro.2023.102492 (2023).","journal-title":"STAR Protoc."},{"key":"1266_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo2003","volume":"8","author":"Y Choi","year":"2023","unstructured":"Choi, Y. et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Sci. Immunol. 8, eabo2003 https:\/\/doi.org\/10.1126\/sciimmunol.abo2003 (2023).","journal-title":"Sci. Immunol."},{"key":"1266_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera, M. et al. A distinct fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628, 424\u2013432 https:\/\/doi.org\/10.1038\/s41586-024-07182-w (2024).","journal-title":"Nature"},{"key":"1266_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2023-001305","volume":"9","author":"MS Farrell","year":"2024","unstructured":"Farrell, M. S. et al. Surgical and procedural antibiotic prophylaxis in the surgical ICU: an American association for the surgery of trauma critical care committee clinical consensus document. Trauma Surg. Acute Care Open 9, e001305 https:\/\/doi.org\/10.1136\/tsaco-2023-001305 (2024).","journal-title":"Trauma Surg. Acute Care Open"},{"key":"1266_CR61","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01857-24","volume":"69","author":"C Pitcock","year":"2025","unstructured":"Pitcock, C., Burgess, D. S. & Olney, K. B. Optimizing cefazolin dosing for central nervous system infections: insights from population pharmacokinetics and Monte Carlo simulations. Antimicrob. Agents Chemother. 69, e0185724 https:\/\/doi.org\/10.1128\/aac.01857-24 (2025).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1266_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1126\/science.abp9563","volume":"380","author":"YE Chen","year":"2023","unstructured":"Chen, Y. E. et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science 380, 203\u2013210 https:\/\/doi.org\/10.1126\/science.abp9563 (2023).","journal-title":"Science"},{"key":"1266_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aak9537","author":"JH Zheng","year":"2017","unstructured":"Zheng, J. H. et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aak9537 (2017).","journal-title":"Sci. Transl. Med."},{"key":"1266_CR64","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/104303402320139005","volume":"13","author":"I King","year":"2002","unstructured":"King, I. et al. Tumor-targeted salmonella expressing cytosine deaminase as an anticancer agent. Hum. Gene Ther. 13, 1225\u20131233 https:\/\/doi.org\/10.1089\/104303402320139005 (2002).","journal-title":"Hum. Gene Ther."},{"key":"1266_CR65","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41587-025-02623-x","volume":"43","author":"ER Ballister","year":"2025","unstructured":"Ballister, E. R. et al. The emerging landscape of engineered bacteria cancer therapies. Nat. Biotechnol. 43, 672\u2013676 https:\/\/doi.org\/10.1038\/s41587-025-02623-x (2025).","journal-title":"Nat. Biotechnol."},{"key":"1266_CR66","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.apsb.2022.09.016","volume":"13","author":"Z Mi","year":"2023","unstructured":"Mi, Z. et al. Salmonella-mediated blood\u2013brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo\/bacterial glioma therapy. Acta Pharm. Sin. B 13, 819\u2013833 https:\/\/doi.org\/10.1016\/j.apsb.2022.09.016 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"1266_CR67","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.canlet.2018.06.031","volume":"433","author":"M Wen","year":"2018","unstructured":"Wen, M. et al. Genetically-engineered Salmonella typhimurium expressing TIMP-2 as a therapeutic intervention in an orthotopic glioma mouse model. Cancer Lett. 433, 140\u2013146 https:\/\/doi.org\/10.1016\/j.canlet.2018.06.031 (2018).","journal-title":"Cancer Lett."},{"key":"1266_CR68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2174\/0115680096344636250101074632","volume":"26","author":"Y Ji","year":"2026","unstructured":"Ji, Y. et al. Enhanced efficacy of radiation therapy against glioblastoma by attenuated salmonella carrying co-expression plasmids with siRNA\u2013PDL1 and endostatin. Curr. Cancer Drug. Targets 26, 443\u2013456 https:\/\/doi.org\/10.2174\/0115680096344636250101074632 (2026).","journal-title":"Curr. Cancer Drug. Targets"},{"key":"1266_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48606-5","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat. Commun. 15, 4241 https:\/\/doi.org\/10.1038\/s41467-024-48606-5 (2024).","journal-title":"Nat. Commun."},{"key":"1266_CR70","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/ijc.24957","volume":"126","author":"G Xiong","year":"2010","unstructured":"Xiong, G. et al. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2. Int. J. Cancer 126, 2622\u20132634 https:\/\/doi.org\/10.1002\/ijc.24957 (2010).","journal-title":"Int. J. Cancer"},{"key":"1266_CR71","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392\u2013400 https:\/\/doi.org\/10.1038\/nm.4517 (2018).","journal-title":"Nat. Med."},{"key":"1266_CR72","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","volume":"167","author":"G Sharon","year":"2016","unstructured":"Sharon, G., Sampson, T. R., Geschwind, D. H. & Mazmanian, S. K. The central nervous system and the gut microbiome. Cell 167, 915\u2013932 https:\/\/doi.org\/10.1016\/j.cell.2016.10.027 (2016).","journal-title":"Cell"},{"key":"1266_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature 535, 75\u201384 https:\/\/doi.org\/10.1038\/nature18848 (2016).","journal-title":"Nature"},{"key":"1266_CR74","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41579-018-0089-x","volume":"16","author":"RJ Lamont","year":"2018","unstructured":"Lamont, R. J., Koo, H. & Hajishengallis, G. The oral microbiota: dynamic communities and host interactions. Nat. Rev. Microbiol. 16, 745\u2013759 https:\/\/doi.org\/10.1038\/s41579-018-0089-x (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"1266_CR75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbi.2004.09.002","volume":"19","author":"LE Goehler","year":"2005","unstructured":"Goehler, L. E. et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 19, 334\u2013344 https:\/\/doi.org\/10.1016\/j.bbi.2004.09.002 (2005).","journal-title":"Brain Behav. Immun."},{"key":"1266_CR76","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2018.00216","volume":"12","author":"M Jaglin","year":"2018","unstructured":"Jaglin, M. et al. Indole, a signaling molecule produced by the gut microbiota, negatively impacts emotional behaviors in rats. Front. Neurosci. 12, 216 https:\/\/doi.org\/10.3389\/fnins.2018.00216 (2018).","journal-title":"Front. Neurosci."},{"key":"1266_CR77","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.celrep.2014.10.032","volume":"9","author":"C Chimerel","year":"2014","unstructured":"Chimerel, C. et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 9, 1202\u20131208 https:\/\/doi.org\/10.1016\/j.celrep.2014.10.032 (2014).","journal-title":"Cell Rep."},{"key":"1266_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12648","author":"P Larraufie","year":"2017","unstructured":"Larraufie, P., Dore, J., Lapaque, N. & Blottiere, H. M. TLR ligands and butyrate increase Pyy expression through two distinct but inter-regulated pathways. Cell Microbiol. https:\/\/doi.org\/10.1111\/cmi.12648 (2017).","journal-title":"Cell Microbiol."},{"key":"1266_CR79","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 https:\/\/doi.org\/10.1038\/nn.4030 (2015).","journal-title":"Nat. Neurosci."},{"key":"1266_CR80","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","volume":"172","author":"MS Thion","year":"2018","unstructured":"Thion, M. S. et al. Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 172, 500\u2013516 e516 https:\/\/doi.org\/10.1016\/j.cell.2017.11.042 (2018).","journal-title":"Cell"},{"key":"1266_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy, S. S. et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 5, eaau3333 https:\/\/doi.org\/10.1126\/sciadv.aau3333 (2019).","journal-title":"Sci. Adv."},{"key":"1266_CR82","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-121918","volume":"36","author":"S Poole","year":"2013","unstructured":"Poole, S., Singhrao, S. K., Kesavalu, L., Curtis, M. A. & Crean, S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer\u2019s disease brain tissue. J. Alzheimers Dis. 36, 665\u2013677 https:\/\/doi.org\/10.3233\/JAD-121918 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"1266_CR83","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrn3029","volume":"12","author":"K Kristensson","year":"2011","unstructured":"Kristensson, K. Microbes\u2019 roadmap to neurons. Nat. Rev. Neurosci. 12, 345\u2013357 https:\/\/doi.org\/10.1038\/nrn3029 (2011).","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01266-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01266-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:53:42Z","timestamp":1789988022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01266-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":83,"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01266-z","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"20 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.W. is listed as an inventor on a US patent application (PCT\/US17\/53.717) submitted by the University of Texas MD Anderson Cancer Center that covers methods to enhance immune checkpoint blockade responses by modulating the microbiome; she reports compensation for speaker\u2019s bureau and honoraria from PeerView and serves as a consultant and\/or advisory board member for Ferring Pharmaceuticals, Gustave Roussy Cancer Center, OSE Immunotherapeutics, Bayer Therapeutics, James Cancer Center OSU and Daiichi Sankyo. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}